Cymbalta: Comprehensive Relief for Chronic Pain and Depression
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.54 | $46.07 (0%) | 🛒 Add to cart |
| 60 | $1.08 | $92.14 $65.10 (29%) | 🛒 Add to cart |
| 90 | $0.92 | $138.21 $83.13 (40%) | 🛒 Add to cart |
| 120 | $0.84 | $184.28 $101.15 (45%) | 🛒 Add to cart |
| 180 | $0.77 | $276.42 $139.21 (50%) | 🛒 Add to cart |
| 270 | $0.72 | $414.62 $195.29 (53%) | 🛒 Add to cart |
| 360 | $0.69
Best per pill | $552.83 $249.38 (55%) | 🛒 Add to cart |
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.50 | $75.11 (0%) | 🛒 Add to cart |
| 60 | $1.77 | $150.23 $106.16 (29%) | 🛒 Add to cart |
| 90 | $1.52 | $225.34 $137.21 (39%) | 🛒 Add to cart |
| 120 | $1.40 | $300.45 $168.25 (44%) | 🛒 Add to cart |
| 180 | $1.28 | $450.68 $230.35 (49%) | 🛒 Add to cart |
| 270 | $1.20
Best per pill | $676.02 $323.49 (52%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.74 | $82.12 (0%) | 🛒 Add to cart |
| 60 | $1.97 | $164.25 $118.18 (28%) | 🛒 Add to cart |
| 90 | $1.70 | $246.37 $153.23 (38%) | 🛒 Add to cart |
| 120 | $1.58 | $328.49 $189.28 (42%) | 🛒 Add to cart |
| 180 | $1.45 | $492.74 $260.39 (47%) | 🛒 Add to cart |
| 270 | $1.37
Best per pill | $739.11 $369.56 (50%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.37 | $101.15 (0%) | 🛒 Add to cart |
| 60 | $2.64 | $202.30 $158.24 (22%) | 🛒 Add to cart |
| 90 | $2.40 | $303.46 $216.33 (29%) | 🛒 Add to cart |
| 120 | $2.28 | $404.61 $273.41 (32%) | 🛒 Add to cart |
| 180 | $2.16 | $606.91 $388.58 (36%) | 🛒 Add to cart |
| 270 | $2.08
Best per pill | $910.37 $561.85 (38%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Cymbalta (duloxetine) is a prescription medication classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), approved for the management of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Its dual mechanism targets both serotonin and norepinephrine neurotransmitters, offering a balanced approach to mood stabilization and pain modulation. Clinically, it demonstrates efficacy in improving emotional symptoms and physical discomfort, providing a multifaceted therapeutic option for patients with overlapping conditions. Proper diagnosis and ongoing medical supervision are essential for optimizing treatment outcomes and minimizing risks.
Features
- Active ingredient: Duloxetine hydrochloride
- Available in delayed-release capsules: 20 mg, 30 mg, 60 mg
- Dual reuptake inhibition of serotonin and norepinephrine
- FDA-approved for multiple indications including MDD, GAD, and chronic pain conditions
- Once-daily dosing regimen for patient convenience
- Delayed-release formulation designed to reduce gastrointestinal irritation
Benefits
- Alleviates symptoms of major depressive disorder, helping restore emotional balance and daily functioning.
- Reduces pervasive worry and physical symptoms associated with generalized anxiety disorder.
- Provides significant relief from neuropathic pain in conditions such as diabetic peripheral neuropathy.
- Decreases widespread pain and improves quality of life for individuals with fibromyalgia.
- Helps manage chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain.
- Supports overall functional improvement by addressing both mood and pain-related barriers.
Common use
Cymbalta is commonly prescribed for the treatment of major depressive disorder (MDD) in adults, offering relief from persistent sadness, loss of interest, and related somatic symptoms. It is also indicated for generalized anxiety disorder (GAD), helping to reduce excessive anxiety and worry. Additionally, it is utilized in the management of diabetic peripheral neuropathic pain, providing analgesia for nerve damage associated with diabetes. For patients with fibromyalgia, Cymbalta aids in reducing widespread pain and improving physical function. It is further approved for chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic low back pain, making it a versatile option in both psychiatry and pain management.
Dosage and direction
The recommended starting dose for most adults is 30 mg once daily for one week, after which it may be increased to 60 mg once daily, depending on tolerability and therapeutic response. For some conditions, such as fibromyalgia or maintenance treatment of MDD, doses up to 120 mg per day have been studied, though 60 mg is often the target maintenance dose. Cymbalta should be taken whole with water, with or without food, to minimize potential gastrointestinal upset. It is important to swallow the capsule intact and not to crush, chew, or open it, as this may affect the delayed-release properties. Dosage adjustments may be necessary for patients with hepatic or severe renal impairment. Always follow the prescribing physician’s instructions and do not alter the dose without consultation.
Precautions
Patients should be monitored for clinical worsening, suicidality, or unusual changes in behavior, especially during the initial few months of therapy or after dosage changes. Cymbalta may increase the risk of bleeding; caution is advised in patients taking anticoagulants or with a history of bleeding disorders. It can cause elevation in blood pressure; regular monitoring is recommended. Use with caution in patients with a history of mania or seizures. Discontinuation symptoms may occur upon abrupt cessation; a gradual taper is recommended under medical supervision. Patients should avoid alcohol while taking Cymbalta due to potential additive effects on the central nervous system. It may cause dizziness or somnolence, affecting the ability to drive or operate machinery.
Contraindications
Cymbalta is contraindicated in patients with known hypersensitivity to duloxetine or any of the inactive ingredients in the formulation. It must not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to the risk of serotonin syndrome. Avoid use in patients with uncontrolled narrow-angle glaucoma. Cymbalta is contraindicated in patients with severe hepatic impairment, end-stage renal disease (requiring dialysis), or those with a creatinine clearance less than 30 mL/min.
Possible side effect
Common side effects include nausea, dry mouth, somnolence, fatigue, constipation, dizziness, decreased appetite, and increased sweating. Some patients may experience insomnia, anxiety, or blurred vision. Less frequently, sexual dysfunction, weight changes, or orthostatic hypotension may occur. Serious side effects can include hepatotoxicity, hyponatremia, serotonin syndrome, severe skin reactions, or angle-closure glaucoma. Patients should report any unusual symptoms, such as persistent headache, confusion, rapid heart rate, or signs of allergic reaction, to their healthcare provider promptly.
Drug interaction
Cymbalta has a potential for significant interactions with other medications. Concomitant use with MAOIs is contraindicated. It may interact with other serotonergic drugs (e.g., SSRIs, tramadol, triptans) increasing the risk of serotonin syndrome. Use with warfarin or NSAIDs may elevate bleeding risk. CYP1A2 inhibitors (e.g., fluvoxamine) can increase duloxetine concentrations, while inducters may decrease efficacy. Caution is advised with drugs that affect blood pressure or heart rate. Discuss all current medications, including over-the-counter products and herbal supplements, with a healthcare provider before starting Cymbalta.
Missed dose
If a dose is missed, take it as soon as remembered, unless it is close to the time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not take a double dose to make up for a missed one, as this may increase the risk of side effects. Maintaining a consistent daily routine can help avoid missed doses and ensure stable therapeutic levels.
Overdose
Symptoms of overdose may include somnolence, coma, serotonin syndrome, seizures, vomiting, or tachycardia. In cases of suspected overdose, seek immediate medical attention or contact a poison control center. Provide supportive care, including monitoring of vital signs and symptomatic treatment. There is no specific antidote for duloxetine overdose; management focuses on stabilization and treatment of presenting symptoms.
Storage
Store Cymbalta capsules at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container. Keep away from moisture, light, and excessive heat. Do not store in the bathroom or other humid areas. Keep out of reach of children and pets. Dispose of any unused or expired medication properly, following local guidelines or through a medication take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Individual responses to medication may vary.
Reviews
Clinical studies and patient reports indicate that Cymbalta can be effective for reducing symptoms of depression, anxiety, and chronic pain, with many users noting improved daily functioning. However, experiences vary; some individuals report significant side effects such as nausea or withdrawal symptoms upon discontinuation. It is essential to discuss benefits and risks with a healthcare provider to determine if Cymbalta is appropriate for your specific condition.